Trials Starting With "H"

HART-II: Heart Failure Adherence and Retention Trial II

      -Late-Breaking Clinical Trial Results Presented at ACC 2000 by Dr. A. Ross

 

HAS-BLED: A New Simple Novel Risk Score for Predicting Bleeding Risk in an Anticoagulated Atrial Fibrillation Cohort: Validation Against Contemporary Bleeding Risk Schemas

      -Overview by Dr. Gregory Lip

 

HAT: The Home Automated External Defibrillator Trial

      -Late-Breaking Clinical Trial Results Presented at ACC 2008 by Dr. Gust H. Bardy

 

HEBE III: A Single Dose of Erythropoietin in ST-Elevation Myocardial Infarction

      -Trial Overview by Dr. Adriaan A. Voors (ESC 2010)

 

HDL Cholesterol Study

      -Effects of High Doses of Simvastatin and Atorvastatin on High-Density Lipoprotein Cholesterol and Apolipoprotein A-1 by Dr. John R. Crouse III

HFHC: The Heart Failure Home Care Trial

      -Late-Breaking Clinical Trial Results Presented at ACC 2008 by Dr. Ozlem Soran

 

HOOPS: A Prospective Cluster Randomized Trial of Pharmacist Intervention to Prevent Hospitalization and Death in Patients with Heart Failure

      -Trial Overview by Dr. Richard Lowrie (AHA 2011)

HOPE: Heart Outcomes Prevention Evaluation

      -Effects of an Angiotensin-Converting Enzyme Inhibitor, Ramipril, on Death from Cardiovascular Causes, Myocardial Infarction, and Stroke in High-Risk Patients by the HOPE Study Investigators

HORIZONS AMI: Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction

      -Protocol Procedures and Overview by Dr. Gregg W. Stone

      -Paclitaxel-Eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction (AMI): One Year Results Presented at TCT 2008 by Dr. Gregg W. Stone

      -Bivalirudin vs. Heparin Plus Glucoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction: 30 Day Results by Dr. Gregg W. Stone

      -Study Design Presented at TCT 2005

      -Infarct Size after Primary Angioplasty Patients With Bivalirudin Compared to Unfractionated Heparin Plus Abciximab in STEMI: MRI Substudy Presented at TCT 2009 by Dr. Jochen Wöhrle

      -Presention at a Non-PCI Facility Requiring Transfer on Long-Term Prognosis in STEMI Patients Undergoing Primary Angioplasty: 1-Year Results Presented at TCT 2009 by Dr. Jochen Wöhrle

      -Impact of Clopidogrel Loading Dose on the Safety and Effectiveness of Bivalirudin in Patients Undergoing Primary Angioplasty for AMI: Presented at ACC 2008 by Dr. George Dangas

      -Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty: Presented at ACC 2009 by Dr. George Dangas

      -Stent Thrombosis Following Primary PCI in STEMI: Predictors, Clinical Impact and Preventive Strategies: Presented at TCT 2009 by Dr. George Dangas

      -Impact of Baseline Renal Function on the Safety and Effectiveness of Bivalirudin in Patients with Acute MI Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. Roxana Mehran

      -Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction: One Year Results Presented at TCT 2008 by Dr. Roxana Mehran

      -Impact of Advanced Age on the Safety and Effectiveness of Bivalirudin in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. Dariusz Dudek

      -Impact of Diabetes Mellitus on the Safety and Effectiveness of Bivalirudin in Patients with AMI Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. Bernhard Witzenbichler

      -Impact of Gender on the Safety and Effectiveness of Bivalirudin in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. L. Grinfeld

      -Major Adverse Events in STEMI Patients Treated with Primary Angioplasty Occur More Frequently at U.S. Compared with Non U.S. Sites: Presented at ACC 2008 by Dr. Bruce R. Brodie

      -A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction - One Year Results by Dr. Gregg W. Stone (TCT 2008)

      -Two-Year Follow-Up From a Prospective, Randomized Trial of Heparin Plus Glycoprotein IIb/IIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare Metal Stents in STEMI by Dr. Gregg W. Stone (TCT 2009)

      -One-Year Outcomes of Primary Angioplasty in Acute Anterior Myocardial Infarction with Bivalirudin Compared to Unfractionated Heparin plus GP IIb/IIIa Inhibitors by Dr. Jochen Wöhrle (TCT 2009)

      -Three-Year Follow-up from a Prospective Randomized Trial of Antithrombin Strategies and Drug-Eluting Stents in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty by Dr. Gregg W. Stone (TCT 2010)

      -Final 3-Year Results by Dr. Gregg W. Stone

 

HORIZONS-SWITCH Analysis: Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction

      -Trial Overview by Dr. George Dangas

 

HOST-ASSURE: Randomized Trial: Adjunctive Cilostazol Versus Double Dose Clopidogrel after PCI with Drug Eluting Stent

      -Trial Overview by Dr. Hyo-Soo Kim (ACC 2012)

HYVET: The Hypertension in the Very Elderly Trial

      -Late-Breaking Clinical Trial Results Presented at ACC 2008 by Dr. Nigel S. Beckett

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster